The epidemiology of glioma in adults: a "state of the science" review.
Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS.
Neuro Oncol. 2014 Jul;16(7):896-913. doi: 10.1093/neuonc/nou087.
Epidemiology and survival of primary intracranial malignant tumor patients with drop metastasis: a population-based analysis.
Jin Y, Lu T, Liu B, Wang Y.
Acta Neurochir (Wien). 2024 Oct 16;166(1):413. doi: 10.1007/s00701-024-06309-2.
Primary intracranial epithelioid hemangioendothelioma: a low-proliferation tumor exhibiting clinically malignant behavior.
Zheng J, Liu L, Wang J, Wang S, Cao Y, Zhao J.
J Neurooncol. 2012 Oct;110(1):119-27. doi: 10.1007/s11060-012-0945-x. Epub 2012 Aug 11.
Recurring intracranial malignant peripheral nerve sheath tumor: case report and systematic review of the literature.
van den Munckhof P, Germans MR, Schouten-van Meeteren AY, Oldenburger F, Troost D, Vandertop WP.
Neurosurgery. 2011 Apr;68(4):E1152-8; discussion E1159. doi: 10.1227/NEU.0b013e31820a1599.
Intracranial malignant triton tumor in a patient with neurofibromatosis type 1: case report and review of the literature.
Smith RE, Kebriaei MA, Gard AP, McComb RD, Bridge JA, Lennarson PJ.
Brain Tumor Pathol. 2014 Apr;31(2):149-54. doi: 10.1007/s10014-013-0147-z. Epub 2013 Apr 30.
Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy.
Wen J, Liu D, Zhu H, Shu K.
J Neuroinflammation. 2024 Sep 16;21(1):226. doi: 10.1186/s12974-024-03222-4.
Targeted next-generation sequencing of malignant peripheral nerve sheath tumor of the pterygopalatine fossa with intracranial metastatic recurrence.
Bao X, Kong X, Yang C, Wu H, Ma W, Wang R.
Medicine (Baltimore). 2018 Jan;97(4):e9636. doi: 10.1097/MD.0000000000009636.
Malignant Intracranial High Grade Glioma and Current Treatment Strategy.
Zhang X, Zhang W, Mao XG, Cao WD, Zhen HN, Hu SJ.
Curr Cancer Drug Targets. 2019;19(2):101-108. doi: 10.2174/1568009618666180530090922.
IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy.
Ye F, Wang L, Li Y, Dong C, Zhou L, Xu J.
Front Immunol. 2024 Jan 5;14:1338244. doi: 10.3389/fimmu.2023.1338244. eCollection 2023.
Disturbed meningeal lymphatic function associated with malignancy and progression in patients with intracranial malignant tumors.
Wang M, Ran L, Liu B, Wei W, Zhu J, Long F, Song X, Zhang J, Zhao Y, Hu G, Yuan X, Wang W.
Med. 2023 Dec 8;4(12):898-912.e4. doi: 10.1016/j.medj.2023.10.001. Epub 2023 Nov 8.
